Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

被引：8
|
作者：
Burke, Michael J. [1 ,2 ]
Ziegler, David S. [3 ]
Bautista Sirvent, Francisco Jose [4 ]
Attarbaschi, Andishe [5 ,6 ]
Gore, Lia [7 ]
Locatelli, Franco [8 ]
O'Brien, Maureen M. [9 ]
Pauly, Melinda [10 ]
Obreja, Mihaela [11 ]
Morris, Christopher L. [11 ]
Baruchel, Andre [12 ,13 ]
机构：
[1] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
[2] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[3] Sydney Childrens Hosp, Randwick, NSW, Australia
[4] Hosp Nino Jesus, Serv Oncol Pediat, Madrid, Spain
[5] St Anna Childrens Hosp, Vienna, Austria
[6] Childrens Canc Res Inst, Vienna, Austria
[7] Univ Colorado, Childrens Hosp Colorado, Peds Heme Onc BMT CT, Aurora, CO USA
[8] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol Cell & Gene Therapy, Rome, Italy
[9] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[10] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA
[11] Amgen Inc, Thousand Oaks, CA USA
[12] Hop Univ Robert Debre, Serv Hematol & Oncol Pediat, AP HP, Paris, France
[13] Univ Paris Dider, Paris, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3873
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)
    Gasparetto, Cristina
    Schiller, Gary J.
    Callander, Natalie Scott
    Lentzsch, Suzanne
    Tuchman, Sascha A.
    Bahlis, Nizar
    White, Darrell J.
    Chen, Christine I.
    Sutherland, Heather J.
    Baljevic, Muhamed
    Kotb, Rami
    Leblanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Bensinger, William I.
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Lipe, Brea C.
    BLOOD, 2019, 134
  • [42] COMBINATION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    LISTER, A
    WHITEHOUSE, M
    CROWTHER, D
    WRIGLEY, P
    BEARD, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 302 - 302
  • [43] Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
    Katsuyoshi Koh
    Chitose Ogawa
    Yasuhiro Okamoto
    Kazuko Kudo
    Jiro Inagaki
    Tsuyoshi Morimoto
    Hideya Mizukami
    Evelyne Ecstein-Fraisse
    Atsushi Kikuta
    International Journal of Hematology, 2016, 104 : 245 - 255
  • [44] Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
    Koh, Katsuyoshi
    Ogawa, Chitose
    Okamoto, Yasuhiro
    Kudo, Kazuko
    Inagaki, Jiro
    Morimoto, Tsuyoshi
    Mizukami, Hideya
    Ecstein-Fraisse, Evelyne
    Kikuta, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (02) : 245 - 255
  • [45] Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomibbased chemotherapy
    Zhao, Junmei
    Wang, Chao
    Song, Yongping
    Liu, Yuzhang
    Fang, Baijun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 211 - 214
  • [46] Importance of blinatumomab in relapsed or refractory acute lymphoblastic leukemia B
    Machet, Antoine
    Gallego-Hernanz, Pilar
    Torregrosa-Diaz, Jose
    Leleu, Xavier
    HEMATOLOGIE, 2016, 22 (01): : 17 - 18
  • [47] Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis
    Baruchel, Andre
    Abrahamsson, Jonas
    Bertrand, Yves
    Gonzalez, Oscar
    Nysom, Karsten
    Quinones, Willy
    Rizzari, Carmelo
    Buechner, Jochen
    Cesaro, Simone
    Duarte, Joaquin
    Fagioli, Franca
    Kang, Hyoung Jin
    Kattamis, Antonis
    Leverger, Guy
    Ludwig, Kathleen
    Makiya, Monica L.
    Micalizzi, Concetta
    Nelken, Brigitte
    Tondel, Camilla
    Yoo, Keon Hee
    Ivanina, Inna
    Brillac, Claire
    Wang, Lynn
    Oprea, Corina
    Abbadessa, Giovanni
    Zwaan, C. Michel
    BLOOD, 2021, 138
  • [48] Phase I/II study of clofarabine plus cyclophosphamide in adults with relapsed and refractory acute lymphoblastic leukemia (ALL)
    Faderl, Stefan
    Thomas, Deborah A.
    Gandhi, Varsha
    Borthakur, Gautam
    Huang, Xuelin
    Plunkett, William
    Burger, Jan
    Cortes, Jorge
    O'Brien, Susan
    Ravandi, Farhad
    Bretz, Jennie
    Kwari, Monica
    Kantarjian, Hagop M.
    BLOOD, 2007, 110 (11) : 152B - 152B
  • [49] Phase 2 Study of Blinatumomab in Japanese Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)
    Kobayashi, Yukio
    Zimmerman, Zachary F.
    Oh, Iekuni
    Maeda, Yoshinobu
    Minami, Hironobu
    Miyamoto, Toshihiro
    Sakura, Toru
    Iida, Hiroatsu
    Chen, Yuqi
    Kiyoi, Hitoshi
    BLOOD, 2018, 132
  • [50] A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes
    Zeidan, Amer M.
    Borate, Uma
    Pollyea, Daniel A.
    Brunner, Andrew M.
    Roncolato, Fernando
    Garcia, Jacqueline S.
    Filshie, Robin
    Odenike, Olatoyosi
    Watson, Anne Marie
    Krishnadasan, Ravitharan
    Bajel, Ashish
    Naqvi, Kiran
    Zha, Jiuhong
    Cheng, Wei-Han
    Zhou, Ying
    Hoffman, David
    Harb, Jason G.
    Potluri, Jalaja
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (02) : 272 - 281
12345